Search

Displaying results 901 - 910 of 3020 in total
  1. Drug

    Purslane

    go.drugbank.com/drugs/DB14327
    Approved

    Purslane is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  2. Drug

    Pentaerythritol tetranitrate

    go.drugbank.com/drugs/DB06154
    ApprovedWithdrawn

    It is recognized by the FDA to be a coronary vasodilator in the treatment of heart conditions such as angina [L2395].

  3. Drug

    Aloe vera flower

    go.drugbank.com/drugs/DB14254
    Approved

    Aloe vera flower is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  4. Drug

    Corydalis ambigua tuber

    go.drugbank.com/drugs/DB14279
    Approved

    Corydalis ambigua tuber is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

    Synonyms: Yan Hu Suo (Corydalis Ambigua)
  5. Drug

    Lonicera caprifolium flower

    go.drugbank.com/drugs/DB14280
    Approved

    Lonicera caprifolium flower is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  6. Drug

    Larix sibirica wood

    go.drugbank.com/drugs/DB14289
    ApprovedWithdrawn

    Larix sibirica wood is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  7. Drug

    Apricot kernel oil

    go.drugbank.com/drugs/DB14324
    Approved

    Apricot kernel oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  8. Drug

    Azadirachta indica leaf

    go.drugbank.com/drugs/DB14352
    Approved

    Azadirachta indica leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  9. Drug

    Larotrectinib

    go.drugbank.com/drugs/DB14723
    ApprovedInvestigational

    It was notable for being the second tissue-agnostic chemotherapy ever approved by the FDA.[L4847]. On April 10, 2025, the FDA granted full drug approval.[L52805] … [L49821] Larotrectinib was granted accelerated approval by the FDA in November 2018 for the treatment of Trk-positive solid tumors.

  10. Drug

    Imetelstat

    go.drugbank.com/drugs/DB14909
    ApprovedInvestigational

    [A187838] Imetelstat received FDA approval in June 2024 for use in certain patients with MDS who have transfusion-dependent anemia and are unable to use ESAs.[L50883,L50888]